文献速递角膜与眼表疾病眼整形与眼眶

史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症患者眼睑表皮中前列腺素E2受体3的表达

Expression of prostaglandin E2 receptor 3 in the eyelid epidermis of patients with Stevens-Johnson syndrome/toxic epidermal necrolysis.
PubMed 文献 · Br J Ophthalmol · 2019-04-18

本研究通过免疫组化检测5例SJS/TEN患者与5例无SJS/TEN对照者眼睑表皮中EP3蛋白表达,发现两组表达相同;体外实验显示PGE2及选择性EP3激动剂可抑制poly(I:C)诱导的趋化因子配体5和趋化因子基序配体10产生。结论认为慢性期SJS/TEN眼睑表皮EP3表达未下调,可能参与抑制皮肤炎症。

要点

  • SJS/TEN患者眼睑表皮EP3表达与无SJS/TEN对照者相同。
  • PGE2及选择性EP3激动剂可抑制poly(I:C)诱导的趋化因子配体5和趋化因子基序配体10产生。
  • 慢性期SJS/TEN眼睑表皮EP3表达未下调,与结膜上皮不同。

核心结论

  • 慢性期SJS/TEN患者眼睑表皮中EP3蛋白有表达且未下调,与结膜上皮不同。
  • PGE2可通过EP3抑制人表皮角质形成细胞的细胞因子产生。
  • 表皮中EP3表达可能有助于慢性期SJS/TEN皮肤炎症的沉默。

研究设计与样本

  • 免疫组化研究纳入5例SJS/TEN患者和5例无SJS/TEN对照者,均因倒睫手术获取眼睑样本。
  • 体外实验采用ELISA和定量逆转录聚合酶链反应研究人表皮角质形成细胞中EP3功能。

主要发现

  • 免疫组化显示SJS/TEN患者眼睑表皮EP3表达与对照者相同。
  • PGE2和选择性EP3激动剂抑制poly(I:C)刺激诱导的趋化因子配体5和趋化因子基序配体10产生及表达。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/AIMS: In a previous genome-wide association study of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) patients we reported the association between SJS/TEN and the prostaglandin E receptor 3 (PTGER3) gene, and that its protein PGE2 receptor 3 (EP3) was markedly downregulated in the conjunctival epithelium of SJS/TEN patients. Here we examined EP3 expression of the eyelid epidermis in SJS/TEN patients with severe ocular complications and investigated the function of EP3. METHODS: For the immunohistochemical study, we obtained eyelid samples from five SJS/TEN patients and five patients without SJS/TEN (control subjects) who were undergoing surgery to treat trichiasis, and investigated the expression of EP3 protein in the epidermis of those samples. To investigate the EP3 function in the human epidermal keratinocytes, we performed ELISA and quantitative reverse transcription polymerase chain reaction, since it is reported that PGE2 suppresses cytokine production via EP3 in human conjunctival epithelium. RESULTS: The results of the immunohistochemical study revealed that EP3 expression in the eyelid epidermis of the SJS/TEN patients was the same as that in the controls. PGE2 and a selective EP3 agonist suppressed cytokine production and expression induced by polyinosine-polycytidylic acid stimulation, such as chemokine ligand 5 and chemokine motif ligand 10. CONCLUSION: Our findings revealed that in chronic-phase SJS/TEN, EP3 protein was expressed in the eyelid epidermis and was not downregulated, unlike in conjunctival epithelium, and that PGE2 could suppress cytokine production via EP3 in human epidermal keratinocytes. Thus, EP3 expression in the epidermis might contribute to a silencing of skin inflammation in chronic-phase SJS/TEN.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Mieno H, Ueta M, Yamada K, et al. Expression of prostaglandin E2 receptor 3 in the eyelid epidermis of patients with Stevens-Johnson syndrome/toxic epidermal necrolysis. Br J Ophthalmol. 2019. PMID: 31000507. doi:10.1136/bjophthalmol-2018-313587

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。